Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
· cnbc.com · popularity 38/100 · 0 similar stories today · Entrepreneurship & Startups (Business & Finance)
Read the original at cnbc.com →
Summary
The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%.
Found in: CNBC Top News. Rating basis: single outlet; outlet tier 5; 1 feeds; feed position 7.